// App-Quantinova.ai

BSH19‐PO‐101 : Myeloma‐specific oncolytic adenovirus induces significant tumour oncolysis in vitro and in vivo and prevents cell line regrowth

Researchers

Presenter

  • G. Stewart

Principal Investigators

  • S.T. Tazzyman

  • D. Lath

  • J. Down

  • M. Lawson

  • M. Muthana

  • A. Chantry

Medical Centers

  • Department of Oncology & Metabolism, University of Sheffield, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Syndecan-1

  • Translocator protein

Drug/Treatment

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCI‐H929

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved